Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Jun 17;15(6):e40552.
doi: 10.7759/cureus.40552. eCollection 2023 Jun.

Chronic Anti-HMG-CoA Reductase Positive Necrotizing Myositis With Remote Exposure to Statins

Affiliations
Case Reports

Chronic Anti-HMG-CoA Reductase Positive Necrotizing Myositis With Remote Exposure to Statins

Tooba Salar et al. Cureus. .

Abstract

The use of statins may be associated with muscle-related side effects ranging from myalgia to rhabdomyolysis. A rare adverse effect is statin-induced anti-hydroxy-3-methyl-glutaryl-coenzyme A reductase (anti-HMGCR) necrotizing myositis, which may develop after exposure to statins due to autoantibodies against HMG-Co-A reductase. We present the case of a 76-year-old male who developed progressive muscle weakness three years after exposure to statins. He had significantly elevated creatine kinase (CK) levels, despite the discontinuation of statins three years prior. He complained of generalized muscle weakness, and examination revealed reduced strength, especially in the proximal musculature. MRI revealed inflammatory myositis of the medial and posterior compartments of bilateral thighs. Autoimmune workup was positive for anti-HMG-CoA reductase antibodies. Muscle biopsy showed endomysial inflammation with fibrosis and fat replacement, suggesting chronic but active myositis. A diagnosis of chronic anti-HMGCR necrotizing myositis was made. The patient was started on oral prednisone and methotrexate with improvement in symptoms and CK levels. This case highlights a chronic form of a rare cause of myositis that may be a challenge to diagnose given the remote exposure to statins.

Keywords: anti-hmgcr; myopathy; myositis; necrotizing myositis; statins.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. T2 weighted fast relaxation, fast spin echo sequence axial images of the right femur (A) and left femur (B). Right femur: mild diffuse interstitial edema about the posterior aspect of the thigh, moderate intramuscular edema involving the left adductor brevis, adductor magnus, and obturator externus muscles at the level of the upper thigh (circle) with fatty atrophy involving the medial and posterior thigh compartment musculature (arrow). Left femur: moderate diffuse intramuscular edema with scattered areas of fatty atrophy involving the medial and posterior thigh compartment musculature (circle).
Figure 2
Figure 2. Small specimen of skeletal muscle showing polygonal and rounded fibers with increased variability in fiber size (panel B). Internal nuclei are found in about 30% of fibers. Endomysial connective tissue is moderately increased. There are slight interstitial mononuclear inflammatory cell infiltrates (panel A). Step sections of frozen tissue showed few areas of interstitial mononuclear inflammation. Hematoxylin and eosin stain. 20X (panels A, B, C).

Similar articles

Cited by

References

    1. Understanding statin use in America and gaps in patient education (USAGE): an internet-based survey of 10,138 current and former statin users. Cohen JD, Brinton EA, Ito MK, Jacobson TA. https://www.sciencedirect.com/science/article/abs/pii/S1933287412000827. J Clin Lipidol. 2012;6:208–215. - PubMed
    1. Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study. Bruckert E, Hayem G, Dejager S, Yau C, Bégaud B. https://pubmed.ncbi.nlm.nih.gov/16453090/ Cardiovasc Drugs Ther. 2005;19:403–414. - PubMed
    1. Anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase necrotizing myopathy masquerading as a muscular dystrophy in a child. Mohassel P, Foley AR, Donkervoort S, Fequiere PR, Pak K, Bönnemann CG, Mammen AL. https://doi.org/10.1002/mus.25567. Muscle Nerve. 2017;56:1177–1181. - PubMed
    1. Statin muscle-related adverse events. https://www.uptodate.com/contents/statin-muscle-related-adverse-events https://www.uptodate.com/contents/statin-muscle-related-adverse-events
    1. 224th ENMC international workshop: clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016. Allenbach Y, Mammen A, Benveniste O, Stenzel W. https://www.nmd-journal.com/article/S0960-8966(17)31207-5/fulltext. Neuromuscul Disord. 2018;28:87–99. - PubMed

Publication types

LinkOut - more resources